Bernhard Wernly

Bernhard Wernly serves as an Associate Professor at the Institute for General, Family and Preventive Medicine within the Faculty of Medicine at Paracelsus Medical University in Salzburg, Austria. His clinical work extends to the University Clinic for Internal Medicine 1, specializing in Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetology.

His research interests span cardiovascular disease, frailty, mitral valve regurgitation, rheumatoid arthritis, and cohort analysis methodologies. Wernly has made significant contributions to observational studies and systematic reviews, particularly in the context of cardiovascular risk assessment and the impact of inflammatory conditions on cerebrovascular health. His work often leverages the extensive Paracelsus 10,000 cohort for population-based research.

His recent publications demonstrate a strong focus on cardiovascular risk prediction using polygenic risk scores, cerebrovascular complications in rheumatoid arthritis patients, and innovative approaches to public health screening. His research bridges clinical medicine with epidemiological methods, producing insights applicable to both individual patient care and population health strategies.

Wernly maintains an active research profile with 437 publications to date, including original research articles, reviews, and letters to the editor. His work has been published in high-impact journals including European Journal of Preventive Cardiology, Rheumatology International, and Intensive Care Medicine.

His research projects include "Extracellular chromatin burden predicts restenosis and survival after transcatheter aortic valve replacement (TAVI)" (2020-2021) and "Use of peripheral blood derived exosomes for angiogenesis and cardioprotection" (2016-2018), demonstrating his commitment to cardiovascular research and innovative therapeutic approaches.